Multi-center study for evaluation of efficacy and safety of methylphenidate-OROS in children with ADHD

被引：2
|
作者：
Lee, J. H. [1 ]
Jung, C. H. [2 ]
Song, C. J. [3 ]
Choi, S. Y. [4 ]
Jeong, S. H. [5 ]
Chung, U. S. [5 ]
Seo, W. S. [6 ]
Lee, K. H. [3 ]
机构：
[1] Catholic Univ, Taegu, South Korea
[2] Keimyung Univ, Taegu, South Korea
[3] Dongguk Univ, Coll Med, Taegu, South Korea
[4] Fatima Hosp Taegu, Taegu, South Korea
[5] Kyungpook Natl Univ Hosp, Taegu, South Korea
[6] Yeungnam Univ, Taegu, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70890-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S571 / S572
页数：2
相关论文
共 50 条
  • [1] Comparison of the efficacy and safety of OROS® methylphenidate HCl with methylphenidate tid and placebo in children with ADHD
    Swanson, JM
    Wigal, SB
    Lerner, MA
    PEDIATRIC RESEARCH, 2000, 47 (04) : 34A - 34A
  • [2] Evaluation of efficacy and safety of OROS® methylphenidate HCl (MPH) extended-release tablets, methylphenidate tid, and placebo in children with ADHD
    Wolraich, ML
    PEDIATRIC RESEARCH, 2000, 47 (04) : 36A - 36A
  • [3] Efficacy and safety of OROS® methylpheniclate in adults with ADHD:: the long-acting methylphenidate in adult ADHD (LAMDA) trial
    Roesler, M.
    Trott, G. E.
    Philipsen, A.
    Gerwe, M.
    Lee, E.
    Medori, R.
    Schauble, B.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 248 - 248
  • [4] Time Course of Treatment Effect of OROS® Methylphenidate in Children With ADHD
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    Schwarzman, Lesley
    O'Neill, James
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (08) : 697 - 705
  • [5] Cost-effectiveness of long acting methylphenidate-OROS in ADHD youths with suboptimal symptom control on immediate-release methylphenidate in The Netherlands
    Faber, A.
    Van Agthoven, M.
    L, Kalverdijk
    Tobi, H.
    De Jong-van den Berg, L.
    L, Annemans
    Postma, M. J.
    VALUE IN HEALTH, 2006, 9 (06) : A314 - A315
  • [6] Comparison of the impact of OROS methylphenidate HCI with methylphenidate tid and placebo on the sleep of children with ADHD
    Swanson, J
    Sadeh, A
    Lerner, MA
    Wigal, SB
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2000, 21 (05): : 387 - 388
  • [7] Safety and efficacy of 72 mg OROS® methylphenidate (CONCERTA®)
    Lerner, MA
    PEDIATRIC RESEARCH, 2004, 55 (04) : 4A - 4A
  • [8] Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study
    Jason E. Kemner
    H. Lynn Starr
    Patrick E. Ciccone
    Christa G. Hooper-Wood
    R. Steve Crockett
    Advances in Therapy, 2005, 22 : 498 - 512
  • [9] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [10] Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD:: A multicenter, randomized prospective study
    Kemner, JE
    Starr, HL
    Ciccone, PE
    Hooper-Wood, CG
    Crockett, RS
    ADVANCES IN THERAPY, 2005, 22 (05) : 498 - 512
12345